Aspirin and Neutrophils in Preeclampsia

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

April 27, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

PreeclampsiaNeutrophilImmunologyPregnancy

Interventions

DIAGNOSTIC_TEST

Blood test

Blood tests will be taken at 12, 20, 28 and 36 weeks gestation to assess the immune profile and omic profile.

Trial Locations (1)

RECRUITING

Barts Health NHS Trust, The Royal London Hospital, London

All Listed Sponsors

lead

Queen Mary University of London

OTHER

NCT04974892 - Aspirin and Neutrophils in Preeclampsia | Biotech Hunter | Biotech Hunter